19 Jan 2021
Society for Endocrinology members are also members of the International Society of Endocrinology (ISE).
Register to join the ISE webinar taking place on Tuesday 26 January, at 4:00 - 5:30 PM CET, to take part in an interactive discussion with top experts. The webinar will explore the role of GLP-1 RAs in the current landscape of incretin therapies for type 2 diabetes. After the session, you will be invited to solve a CME-accredited case study on the ISE Global Education Hub, to apply what you learned.
The webinar will consist of the following interactive parts:
• Part 1: Have diabetes goals changed? What is new and relevant to Diabetes Management – By Dr Abbas Raza (Pakistan)
• Part 2: GLP-1 Agonist: A closer look at role in Diabetes Management – by Dr David D’Alessio (USA)
• Part 3: Interactive Case (best practices/patient-centered approach) – by Dr Alvin Powers (USA)
• Part 4: Meet the Experts (Debate and Q&A)
Find out more and register.
Study links premature ovarian insufficiency (POI) to risk of mortality
17 May 2024
Cardiovascular disease mortality associated with low testosterone in men
17 May 2024
People with obesity using semaglutide see cardiovascular improvements
17 May 2024
Men with obesity lose more weight with cash incentives, research says
17 May 2024
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024